文献速递消化道出血肝病

红细胞输注实践对静脉曲张性与非静脉曲张性消化道出血患者住院死亡率的影响:美国20年全国回顾性分析

The impact of red blood cell transfusion practices on inpatient mortality in variceal and non-variceal gastrointestinal bleeding patients: a 20-year US nationwide retrospective analysis.
PubMed 文献 · Aliment Pharmacol Ther · 2022-05-19

基于美国全国住院患者样本(1999-2018)的回顾性分析,纳入10,228,524例上消化道出血出院患者,其中755,135例为静脉曲张性出血。倾向匹配后,静脉曲张性出血者输注红细胞与住院死亡率增加22%相关,非静脉曲张性出血者增加9%;静脉曲张性出血者接受输血后住院死亡风险约为非静脉曲张性出血者的3.8倍(OR 3.8,95%CI 3.7-3.8,p<0.001)。

要点

  • 倾向匹配后,静脉曲张性出血输注红细胞与住院死亡率增加22%相关,非静脉曲张性出血增加9%。
  • 接受输血时,静脉曲张性出血者住院死亡风险约为非静脉曲张性出血者的3.8倍(OR 3.8,95%CI 3.7-3.8,p<0.001)。
  • 两组红细胞输注率自2011年以来均下降,但静脉曲张性出血者仍较高;上消化道出血死亡率自1999年以来持续下降。

核心结论

  • 过去十年红细胞输注率虽下降,但静脉曲张性出血者仍较高;红细胞输注对静脉曲张性出血者的危害似乎大于非静脉曲张性出血者。

研究设计与样本

  • 美国全国住院患者样本(1999-2018)的回顾性分析,采用算法识别上消化道出血并分为非静脉曲张性与静脉曲张性出血。
  • 共纳入10,228,524例上消化道出血出院患者,其中755,135例为静脉曲张性出血。
  • 为控制出血严重程度,对年龄、性别、休克、需ICU治疗及合并症等基线特征进行倾向匹配。

主要发现

  • 倾向匹配后,静脉曲张性出血者输注红细胞与住院死亡率增加22%相关,非静脉曲张性出血者增加9%。
  • 与非静脉曲张性出血接受输血者相比,静脉曲张性出血接受输血者住院死亡比值比接近四倍(倾向匹配OR 3.8,95%CI 3.7-3.8,p<0.001)。
  • 两组红细胞输注率自2011年以来均下降,但静脉曲张性出血者仍较高;上消化道出血死亡率自1999年以来持续下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies in upper gastrointestinal (GI) bleeding have reported inconsistent outcomes about packed red blood cell (PRBC) transfusion practices. AIM: To assess whether PRBC transfusion is more likely to be dangerous in variceal bleeding than in non-variceal bleeding due to concern of over-transfusion leading to elevated portal pressure. METHODS: We used the Nationwide Inpatient Sample (1999-2018). We identified patients with upper GI bleeding using an algorithmic approach, categorising bleeding from non-variceal or variceal sources. Our primary outcome was all-cause inpatient mortality. To control for the severity of bleeding, we performed propensity matching of baseline features, including age, gender, the presence of shock, the need for ICU care and co-morbidities. We also examined PRBC transfusion, inpatient mortality and hospitalisation rates for both populations. RESULTS: We included 10,228,524 upper GI bleeding discharges; 755,135 patients had variceal bleeding. After propensity matching, PRBC transfusion in variceal bleeders was associated with a 22% increase in inpatient mortality, whereas non-variceal bleeders had a 9% increase in inpatient mortality. Compared to non-variceal bleeders receiving blood transfusion, variceal bleeders had nearly four-fold higher odds of inpatient mortality (propensity-matched OR: 3.8; 95% CI: 3.7-3.8; p < 0.001). Notably, PRBC transfusion rates in both groups have declined since 2011, although it has remained higher in variceal bleeders. Mortality for upper GI bleeding has been declining since 1999. CONCLUSIONS: Although decreased over the last decade, PRBC transfusion rates remain high for variceal bleeders. In addition, PRBC transfusion appears to be more detrimental in variceal bleeders than in non-variceal bleeders.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Radadiya D, Devani K, Rockey DC, et al. The impact of red blood cell transfusion practices on inpatient mortality in variceal and non-variceal gastrointestinal bleeding patients: a 20-year US nationwide retrospective analysis. Aliment Pharmacol Ther. 2022. PMID: 35591774. doi:10.1111/apt.16965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。